
Beta Bionics Faces Class Action Over Alleged Misleading Safety Disclosures
Investors who purchased Beta Bionics common stock between July 30, 2025, and February 24, 2026, are now eligible to join a securities class action lawsuit. The filing follows revelations that the medical device manufacturer allegedly concealed thousands of safety complaints regarding its iLet automated insulin delivery system, triggering sharp declines in share price.

























